Cytocast

About:

Cytocast revolutionizes the fields of drug discovery and personalized treatment through a comprehensive cell simulator.

Website: http://www.cytocast.com/

Twitter/X: cytocast

Top Investors: Bonitás Ventures, FastVentures, Creative Accelerator, Zoiros Ventures, KDT Holding

Description:

Cytocast is leveraging the integration of bioinformatics databases and patient data within a computer model to create a groundbreaking cell simulation software. This software holds the potential to revolutionize patient treatment, significantly impact the drug development process, and enable the identification of optimal therapeutic options. The comprehensive cell model that forms the basis of the technology combines molecular knowledge of how healthy cells function to understand the effects of perturbations caused by diseases and predict how drugs can modify cellular health.

Total Funding Amount:

1.86M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Budapest, Budapest, Hungary

Founded Date:

2019-03-01

Contact Email:

info(AT)cytocast.com

Founders:

Attila Csikász-Nagy, Bence Keömley-Horváth, István Reguly

Number of Employees:

11-50

Last Funding Date:

2023-05-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai